AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34684116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32018274 — intervention group
Group type: EXPERIMENTAL
Intervention: PC6 pressure (4 times a day, for 10 min)
Number of subjects: 90
Study 32018274 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 90
Study 32018274 — intervention group
Group type: COMPARATOR
Intervention: Medication with vitamin B6 and metoclopramide
Number of subjects: 90
Study 34673449 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based therapy
Number of subjects: 22
Study 34673449 — intervention group
Group type: COMPARATOR
Intervention: Therapist-mediated therapy
Number of subjects: 22
Study 34673449 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 22
Study 36418112 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer everolimus-eluting stent (BP-EES)
Number of subjects: 20
Study 36418112 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (DP-EES)
Number of subjects: 20
Study 32809921 — intervention group
Group type: EXPERIMENTAL
Intervention: Constructivist physical education intervention
Number of subjects: 1256
Study 33451495 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinase activity
Number of subjects: 150
Study 33451495 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual kinases
Number of subjects: 150
Study 33451495 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphorylation of known activating or inhibitory sites on kinases
Number of subjects: 150
Study 33451495 — intervention group
Group type: EXPERIMENTAL
Intervention: Motif-based analysis
Number of subjects: 150
Study 36214314 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 78
Study 36214314 — intervention group
Group type: COMPARATOR
Intervention: Transversus abdominis plane (TAP) block
Number of subjects: 78
Study 36592517 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/L Schisandrin B
Number of subjects: 0
Study 36592517 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/L Schisandrin B
Number of subjects: 0
Study 36592517 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mg/L Schisandrin B)
Number of subjects: 0
Study 33772456 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxiphylline (PTX) 400 mg thrice daily and Vitamin E (VE) 400 IU twice daily (PTVE group)
Number of subjects: 69
Study 33772456 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E (VE) alone (VE group)
Number of subjects: 69
Study 33772456 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxiphylline (PTX) and Vitamin E (VE) combination (PTVE group)
Number of subjects: 69
Study 32615392 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (6 g/d for 6 months)
Number of subjects: 120
Study 32615392 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics (6 g/d for 6 months)
Number of subjects: 120
Study 32615392 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin, 6 g/d for 6 months)
Number of subjects: 120
Study 36245316 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruence Couple Therapy (CCT)
Number of subjects: 0
Study 36245316 — intervention group
Group type: COMPARATOR
Intervention: Treatment‐as‐Usual (TAU)
Number of subjects: 0
Study 34791756 — intervention group
Group type: EXPERIMENTAL
Intervention: Natriuresis-guided therapy
Number of subjects: 310
Study 34791756 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 310
Study 33327237 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 0
Study 33327237 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation program
Number of subjects: 0
Study 36150694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryolipolysis (60 minutes, -9°C)
Number of subjects: 10
Study 36150694 — intervention group
Group type: COMPARATOR
Intervention: Surgical flap contouring
Number of subjects: 10
Study 33438146 — intervention group
Group type: EXPERIMENTAL
Intervention: audio with phonocardiogram tracings (combined group)
Number of subjects: 135
Study 33438146 — intervention group
Group type: COMPARATOR
Intervention: audio group (control)
Number of subjects: 135
Study 32739080 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicompartmental knee arthroplasty (BCA)
Number of subjects: 80
Study 32739080 — intervention group
Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 80
Study 36094367 — intervention group
Group type: EXPERIMENTAL
Intervention: End-range Maitland mobilization (EMGr)
Number of subjects: 66
Study 36094367 — intervention group
Group type: EXPERIMENTAL
Intervention: Not end-range Maitland mobilization (nEMGr)
Number of subjects: 66
Study 36094367 — intervention group
Group type: COMPARATOR
Intervention: Sham manual therapy technique (CG)
Number of subjects: 66
Study 32985592 — intervention group
Group type: COMPARATOR
Intervention: Cover Group (CG)
Number of subjects: 28
Study 32985592 — intervention group
Group type: COMPARATOR
Intervention: Fill Group (FG)
Number of subjects: 28
Study 33436684 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffuse Reflectance Spectroscopy (DRS) probing superficial colorectal tissue
Number of subjects: 47
Study 33436684 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffuse Reflectance Spectroscopy (DRS) probing deeper tissue layers
Number of subjects: 47
Study 32383572 — intervention group
Group type: EXPERIMENTAL
Intervention: DfPD®-based dance classes (one hour, twice weekly for 12 weeks)
Number of subjects: 33
Study 32383572 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 33
Study 32383572 — intervention group
Group type: EXPERIMENTAL
Intervention: DfPD®-based dance classes
Number of subjects: 33
Study 33739319 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n=58)
Number of subjects: 150
Study 33739319 — intervention group
Group type: COMPARATOR
Intervention: Counseling group (n=53)
Number of subjects: 150
Study 32835880 — intervention group
Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid (PA)
Number of subjects: 50
Study 32835880 — intervention group
Group type: EXPERIMENTAL
Intervention: MBP using PDT
Number of subjects: 50
Study 32835880 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (NYL)
Number of subjects: 50
Study 32835880 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion (AA)
Number of subjects: 50
Study 32835880 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG (ECYL)
Number of subjects: 50
Study 34686942 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel SDM tool based on the SHARE Approach; consultation time was 11 minutes longer (p < 0.01).
Number of subjects: 18
Study 34686942 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SDM tool); consultation time was shorter than experimental group.
Number of subjects: 18
Study 33530249 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation via helmet
Number of subjects: 0
Study 33530249 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive ventilation via face mask
Number of subjects: 0
Study 34963309 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tPCS at 75 Hz
Number of subjects: 17
Study 34963309 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tPCS at 4 Hz
Number of subjects: 17
Study 34963309 — intervention group
Group type: COMPARATOR
Intervention: Sham a-tPCS
Number of subjects: 17
Study 32359018 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling
Number of subjects: 24
Study 32359018 — intervention group
Group type: COMPARATOR
Intervention: Fractional Er:YAG laser
Number of subjects: 24
Study 33932294 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAINING (6-week group-format advanced training program including plyometric, strengthening, and agility exercises)
Number of subjects: 46
Study 33932294 — intervention group
Group type: COMPARATOR
Intervention: NoTRAINING (age- and sex-matched patients who did not participate in advanced training)
Number of subjects: 46
Study 33932294 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAINING
Number of subjects: 46
Study 33932294 — intervention group
Group type: COMPARATOR
Intervention: NoTRAINING
Number of subjects: 46
Study 32940718 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual dissection
Number of subjects: 100
Study 32940718 — intervention group
Group type: COMPARATOR
Intervention: Textbooks (control)
Number of subjects: 100
Study 32026714 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontitis (PD ≥4 mm and CAL ≥1 mm)
Number of subjects: 2435
Study 32026714 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean percentage PD ≥4 mm
Number of subjects: 2435
Study 32026714 — intervention group
Group type: EXPERIMENTAL
Intervention: Gingival Index (GI)
Number of subjects: 2435
Study 32026714 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaque Index (PI)
Number of subjects: 2435
Study 32026714 — intervention group
Group type: COMPARATOR
Intervention: Tooth brushing
Number of subjects: 2435
Study 35486221 — intervention group
Group type: EXPERIMENTAL
Intervention: MALND
Number of subjects: 996
Study 35486221 — intervention group
Group type: COMPARATOR
Intervention: CALND
Number of subjects: 996
Study 33906234 — intervention group
Group type: COMPARATOR
Intervention: Single-dose ALB (400 mg)
Number of subjects: 176
Study 33906234 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose ALB (400 mg) plus IVM (600 μg/kg)
Number of subjects: 176
Study 33906234 — intervention group
Group type: EXPERIMENTAL
Intervention: ALB (400 mg) for 3 consecutive days
Number of subjects: 176
Study 33906234 — intervention group
Group type: EXPERIMENTAL
Intervention: ALB (400 mg) plus IVM (600 μg/kg) for 3 consecutive days
Number of subjects: 176
Study 34872341 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis combined with EVT (combination-therapy group)
Number of subjects: 633
Study 34872341 — intervention group
Group type: COMPARATOR
Intervention: EVT alone
Number of subjects: 633
Study 34872341 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination-therapy group
Number of subjects: 633
Study 34872341 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase treatment
Number of subjects: 633
Study 32645109 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined protocol (2 sachets of RUTF per day for MUAC < 11.5 cm and/or edema; 1 sachet of RUTF per day for MUAC 11.5 to <12.5 cm)
Number of subjects: 4070
Study 32645109 — intervention group
Group type: COMPARATOR
Intervention: Standard care (weight-based RUTF for SAM; RUSF for MAM)
Number of subjects: 4070
Study 32645109 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined protocol
Number of subjects: 4070
Study 32645109 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 4070
Study 34589541 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided BT
Number of subjects: 14
Study 34589541 — intervention group
Group type: COMPARATOR
Intervention: Standard BT
Number of subjects: 14
Study 36098582 — intervention group
Group type: EXPERIMENTAL
Intervention: Early catheter removal (3 days after surgery)
Number of subjects: 30
Study 36098582 — intervention group
Group type: COMPARATOR
Intervention: Standard catheterization time (7 days after surgery)
Number of subjects: 30
Study 33559518 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby QOL narratives
Number of subjects: 1966
Study 33559518 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby QOL + Family QOL narratives
Number of subjects: 1966
Study 33559518 — intervention group
Group type: EXPERIMENTAL
Intervention: Family QOL narratives
Number of subjects: 1966
Study 33559518 — intervention group
Group type: COMPARATOR
Intervention: Control: no narratives
Number of subjects: 1966
Study 35132653 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred and theory-based educational intervention
Number of subjects: 312
Study 35132653 — intervention group
Group type: COMPARATOR
Intervention: Conventional information/instruction (Control)
Number of subjects: 312
Study 32050853 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV + BFR
Number of subjects: 20
Study 32050853 — intervention group
Group type: COMPARATOR
Intervention: WBV
Number of subjects: 20
Study 35226099 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose rh insulin (400-μIU/mL milk)
Number of subjects: 303
Study 35226099 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose rh insulin (2000-μIU/mL milk)
Number of subjects: 303
Study 35226099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study 33750266 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic acidophilus milk (100 g/day, 107 cfu/g)
Number of subjects: 45
Study 33750266 — intervention group
Group type: COMPARATOR
Intervention: Freshly prepared 'dahi' (100 g/day, 107 cfu/g)
Number of subjects: 45
Study 33750266 — intervention group
Group type: COMPARATOR
Intervention: Thermal processed buffalo milk (100 ml/day)
Number of subjects: 45
Study 36069662 — intervention group
Group type: EXPERIMENTAL
Intervention: Outsmart HPV intervention
Number of subjects: 1227
Study 36069662 — intervention group
Group type: COMPARATOR
Intervention: Standard HPV vaccination information online (control)
Number of subjects: 1227
Study 32290148 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (30 min at 60% maximal aerobic power)
Number of subjects: 10
Study 32290148 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobic exercise (30 s Wingate test)
Number of subjects: 10
Study 32290148 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise (anaerobic and aerobic)
Number of subjects: 10
Study 32290148 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline measurements)
Number of subjects: 10
Study 34038228 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 0
Study 36384551 — intervention group
Group type: EXPERIMENTAL
Intervention: Customised care in response to mental health risk
Number of subjects: 352
Study 36384551 — intervention group
Group type: EXPERIMENTAL
Intervention: Customised care in response to domestic violence
Number of subjects: 352
Study 36384551 — intervention group
Group type: COMPARATOR
Intervention: Standard care (not specified)
Number of subjects: 352
Study 32683390 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical gel containing 0.2% chlorhexidine, 0.5% chitosan, 5% dexpanthenol, 0.15% allantoin, and 0.01% sodium saccharin
Number of subjects: 36
Study 32683390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 32394355 — intervention group
Group type: EXPERIMENTAL
Intervention: Harvest height of 15 cm
Number of subjects: 0
Study 32394355 — intervention group
Group type: EXPERIMENTAL
Intervention: Harvest height of 25 cm
Number of subjects: 0
Study 32394355 — intervention group
Group type: EXPERIMENTAL
Intervention: Harvest height of 35 cm
Number of subjects: 0
Study 32394355 — intervention group
Group type: EXPERIMENTAL
Intervention: Harvest height of 45 cm
Number of subjects: 0
Study 32394355 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual stalks
Number of subjects: 0
Study 32394355 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing harvest height
Number of subjects: 0
Study 32394355 — intervention group
Group type: EXPERIMENTAL
Intervention: Residuals
Number of subjects: 0
Study 32007714 — intervention group
Group type: EXPERIMENTAL
Intervention: CBOP/BEP (carboplatin, bleomycin, vincristine and cisplatin)
Number of subjects: 89
Study 32007714 — intervention group
Group type: COMPARATOR
Intervention: BEP (bleomycin, etoposide and cisplatin)
Number of subjects: 89
Study 32007714 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilising chemotherapy
Number of subjects: 89
Study 34731268 — intervention group
Group type: EXPERIMENTAL
Intervention: GET 73
Number of subjects: 0
Study 34731268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33260292 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong parental support for breakfast as the main daily meal
Number of subjects: 1149
Study 33260292 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal education
Number of subjects: 1149
Study 33260292 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 1149
Study 33260292 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient sleep
Number of subjects: 1149
Study 33260292 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI <25 kg/m2
Number of subjects: 1149
Study 35049111 — intervention group
Group type: EXPERIMENTAL
Intervention: 90° bend angle
Number of subjects: 136
Study 35049111 — intervention group
Group type: COMPARATOR
Intervention: 70° bend angle
Number of subjects: 136
Study 33427851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse navigator‐led ACP pathway
Number of subjects: 759
Study 33427851 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 759
Study 36309950 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa 50 mg with 100 mg IR levodopa and 200 mg entacapone
Number of subjects: 25
Study 36309950 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa 100 mg with 100 mg IR levodopa and 200 mg entacapone
Number of subjects: 25
Study 36309950 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa 50 mg with 100 mg IR levodopa without entacapone
Number of subjects: 25
Study 36309950 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa 100 mg with 100 mg IR levodopa without entacapone
Number of subjects: 25
Study 36309950 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa doses with 200 mg entacapone
Number of subjects: 25
Study 36309950 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa doses
Number of subjects: 25
Study 34937710 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor wearing a white coat
Number of subjects: 286
Study 34937710 — intervention group
Group type: COMPARATOR
Intervention: Doctor not wearing a white coat
Number of subjects: 286
Study 36355846 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (NH)
Number of subjects: 20
Study 36355846 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypobaric hypoxia at the first day of ascent (HH1)
Number of subjects: 20
Study 32601329 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suture
Number of subjects: 134
Study 32601329 — intervention group
Group type: COMPARATOR
Intervention: Interrupted suture
Number of subjects: 134
Study 35446415 — intervention group
Group type: EXPERIMENTAL
Intervention: Substantive Cognitive Impairment (SCI)
Number of subjects: 8772
Study 35446415 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Impairment based on geometric mean (SCI-GM)
Number of subjects: 8772
Study 33450160 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic adrenalectomy (RA-g)
Number of subjects: 160
Study 33450160 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic adrenalectomy (LA-g)
Number of subjects: 160
Study 33450160 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic left adrenalectomy
Number of subjects: 160
Study 32184033 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-gE ELISA
Number of subjects: 397
Study 32184033 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-VZV ELISA
Number of subjects: 397
Study 35597947 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIP intervention (patient navigation intervention)
Number of subjects: 17
Study 34716902 — intervention group
Group type: EXPERIMENTAL
Intervention: RIST4721 300 mg once daily for 28 days
Number of subjects: 34
Study 34716902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 34028170 — intervention group
Group type: EXPERIMENTAL
Intervention: mini‐PCNL
Number of subjects: 67
Study 34028170 — intervention group
Group type: COMPARATOR
Intervention: ESWL
Number of subjects: 67
Study 32907635 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous enoxaparin at the recommended dose of 4,000 IU anti-Xa activity (40 mg/0.4 ml) once daily for 14 days
Number of subjects: 1000
Study 32907635 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 1000
Study 32907635 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous enoxaparin
Number of subjects: 1000
Study 35768027 — intervention group
Group type: EXPERIMENTAL
Intervention: Urologists' recommendations (surgery)
Number of subjects: 108
Study 35768027 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation oncologists' recommendations (radiation)
Number of subjects: 108
Study 35768027 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordance between recommendations
Number of subjects: 108
Study 35768027 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment received by patients
Number of subjects: 108
Study 35768027 — intervention group
Group type: EXPERIMENTAL
Intervention: Discordant recommendations
Number of subjects: 108
Study 33328285 — intervention group
Group type: EXPERIMENTAL
Intervention: AT247
Number of subjects: 19
Study 36429962 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study 32844483 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% atropine
Number of subjects: 207
Study 32844483 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine
Number of subjects: 207
Study 32844483 — intervention group
Group type: COMPARATOR
Intervention: 1% cyclopentolate
Number of subjects: 207
Study 35636787 — intervention group
Group type: EXPERIMENTAL
Intervention: LifeBuoy application
Number of subjects: 669
Study 35636787 — intervention group
Group type: EXPERIMENTAL
Intervention: LifeBuoy+engagement
Number of subjects: 669
Study 35636787 — intervention group
Group type: COMPARATOR
Intervention: Placebo app (attention-matched control)
Number of subjects: 669
Study 32945860 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified ICTs (42 daily and 2 weekly sessions)
Number of subjects: 76
Study 32945860 — intervention group
Group type: COMPARATOR
Intervention: Nongamified ICTs (42 daily and 2 weekly sessions)
Number of subjects: 76
Study 32583468 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplitude-based gating (AG)
Number of subjects: 15
Study 32583468 — intervention group
Group type: EXPERIMENTAL
Intervention: Count-based gating (CG)
Number of subjects: 15
Study 32583468 — intervention group
Group type: COMPARATOR
Intervention: Phase or time-based gating (TG)
Number of subjects: 15
Study 36440473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal drug delivery (IDD)
Number of subjects: 54
Study 36440473 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical management (CMM)
Number of subjects: 54